Further observations on the cystometric and uroflowmetric effects of bethanechol chloride on the human bladder.
We evaluated the cystometric and uroflowmetric effects of bethanechol chloride on non-neurogenic, non-decompensated human bladders. Statistically significant changes were measured using cystometric and uroflowmetric parameters. We discuss the indications and methods for therapy with bethanechol chloride.
D001626:Bethanechol Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D011312:Pressure; D001743:Urinary Bladder / Q000187:drug effects*; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology; D014563:Urodynamics / Q000187:drug effects*
D001626:Bethanechol Compounds